Biotheus
Manufacturing · China · 51-200 Employees
View Company Info for Free
Overview
Headquarters
10b Building 4 No 1 Keji 7th Road Xiang ...Phone Number
+86 7566998555Website
www.biotheus.comRevenue
$13.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Biotheus
Biotheus is a biotech company focused on curing malignant tumors and autoimmune diseases. Biotheus was established in 2018, and is headquartered in China.Explore more
Biotheus Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biotheus your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Biotheus launches new products
Biotheus, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Biotheus has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Biotheus has new funding data
Check out if Biotheus is spiking on competitors!
Click to see if Biotheus had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Biotheus
Earning: See what the market has to say on Biotheus recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Biotheus as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Biotheus is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Biotheus is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Biotheus.
Biotheus financials insights
Gather financial insights about Biotheus, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Other Financing Round
$100M
Biotheus Tech Stack
A closer look at the technologies used by Biotheus
Biotheus News & Media
BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition
On Wednesday, BioNTech SE (NASDAQ:BNTX) agreed to acquire Biotheus, a clinical-stage biotechnology company focused on discovering and developing antibodies for oncological or inflammatory diseases. With the acquisition, BioNTech will obtain full global rights to the late-stage clinical asset BNT327/PM8002, an investigational bispecific antibody targeting PD-L1 and VEGF-A. Also Read: BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential BioNTech will pay BiBioNTech to Acquire Biotheus to Boost Oncology Strategy
MAINZ, Germany, November 13, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Biotheus (“Biotheus”) today announced the signing of a definitive agreement for the acquisition of Biotheus, a clinical-stage biotechnology company dedicated to the discovery and development of novel antibodies to address unmet medical needs of patients with oncological or inflammatory diseases.ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus
VICTORIA, British Columbia & ZHUHAI, China--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, and Biotheus Inc. (Biotheus), a clinical-stage biotech company dedicated to the discovery and development of biologics for oncology and inflammatory diseases, jointly announce that the two parties have entered into a Material Transfer and Evaluation Agreement (MTEA) pertaining to a Talem therapBiotheus Expanded Their Partnership with Hansoh Pharma for Developing EGFR/cMET Bispecific Antibody-Drug Conjugates
ZHUHAI, China, March 15, 2024 /PRNewswire/ -- On March 14, 2024, Biotheus Inc. (Biotheus), a clinical-stage biotech company focusing on the discovery and development of biologics for oncology and inflammatory diseases, and Hansoh Pharmaceutical Group Co., Ltd. (Hansoh Pharma,03692.HK),...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biotheus
Sign Up For FreeTo access detailed company insights
Biotheus is a biotech company focused on curing malignant tumors and autoimmune diseases. Biotheus was established in 2018, and is headquartered in China.... Read More
